APA (7th ed.) Citation

Smith, G. H. R., Henry, W. K., Podzamczer, D., Masiá, M. D. M., Bettacchi, C. J., Arasteh, K., . . . Margolis, D. A. (2021). Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study. Open Forum Infectious Diseases, 8(9), 1. https://doi.org/10.1093/ofid/ofab439

Chicago Style (17th ed.) Citation

Smith, Graham H R., et al. "Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study." Open Forum Infectious Diseases 8, no. 9 (2021): 1. https://doi.org/10.1093/ofid/ofab439.

MLA (9th ed.) Citation

Smith, Graham H R., et al. "Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study." Open Forum Infectious Diseases, vol. 8, no. 9, 2021, p. 1, https://doi.org/10.1093/ofid/ofab439.